These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14629731)

  • 41. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective.
    Afouna MI; Fincher TK; Khan MA; Reddy IK
    Chirality; 2003 May; 15(5):456-65. PubMed ID: 12692892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of single-isomer, multiply charge chiral resolving agents for the continuous, preparative-scale electrophoretic separation of enantiomers based on the principle of equal-but-opposite analyte mobilities.
    Glukhovskiy P; Vigh G
    Electrophoresis; 2000 Jun; 21(10):2010-5. PubMed ID: 10879960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single enantiomer drugs: should they be developed?
    Khan AY; Preskorn SH; Wimalasena K
    Essent Psychopharmacol; 2006; 7(1):15-23. PubMed ID: 16989289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereochemistry and bioequivalence.
    Jamali F
    J Clin Pharmacol; 1992 Oct; 32(10):930-4. PubMed ID: 1447401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Racemates or enantiomers: regulatory approaches.
    Birkett DJ
    Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):479-83. PubMed ID: 2670355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enantiomeric impurity determination in capillary electrophoresis using a highly-sulfated cyclodextrins-based method.
    Matthijs N; Vander Heyden Y
    Biomed Chromatogr; 2006 Aug; 20(8):696-709. PubMed ID: 16240285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The chromatographic separation of enantiomers through nanoscale design.
    Sancho R; Minguillón C
    Chem Soc Rev; 2009 Mar; 38(3):797-805. PubMed ID: 19322471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Characterization of drug, narcotic and psychotropic drug chirality by statistical methods].
    Noszál B; Schiller Z
    Acta Pharm Hung; 1999 Apr; 69(2):85-90. PubMed ID: 10389303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chiral inversion of drugs: coincidence or principle?
    Wsól V; Skálová L; Szotáková B
    Curr Drug Metab; 2004 Dec; 5(6):517-33. PubMed ID: 15578945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association of chiral characteristic with drug withdrawal due to safety: A comparative analysis.
    Aydin V; Bahar A; Vizdiklar C; Akici A
    Br J Clin Pharmacol; 2023 Jan; 89(1):290-298. PubMed ID: 35942905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Separation of chiral pharmaceutical drugs by chromatographic and electrophoretic techniques].
    Morin P
    Ann Pharm Fr; 2009 Jul; 67(4):241-50. PubMed ID: 19596097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selected fundamental aspects of chiral electromigration techniques and their application to pharmaceutical and biomedical analysis.
    Scriba GK
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):373-99. PubMed ID: 11755740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparative resolution of drug racemates to study the chiroptical properties of their enantiomers.
    Thunberg L; Andersson S; Allenmark S; Vessman J
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):431-9. PubMed ID: 11755744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient enantioselective separation of drug enantiomers by immobilised antibody fragments.
    Nevanen TK; Söderholm L; Kukkonen K; Suortti T; Teerinen T; Linder M; Söderlund H; Teeri TT
    J Chromatogr A; 2001 Aug; 925(1-2):89-97. PubMed ID: 11519820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioequivalence of racemic drugs.
    Nerurkar SG; Dighe SV; Williams RL
    J Clin Pharmacol; 1992 Oct; 32(10):935-43. PubMed ID: 1447402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategy for large-scale isolation of enantiomers in drug discovery.
    Leek H; Thunberg L; Jonson AC; Öhlén K; Klarqvist M
    Drug Discov Today; 2017 Jan; 22(1):133-139. PubMed ID: 27693710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enantioselective chromatography as a powerful alternative for the preparation of drug enantiomers.
    Francotte ER
    J Chromatogr A; 2001 Jan; 906(1-2):379-97. PubMed ID: 11215898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
    Brocks DR
    Biopharm Drug Dispos; 2006 Nov; 27(8):387-406. PubMed ID: 16944450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.